MedPath

Assessment of the usefulness of plasma copeptin for diagnosing and predicting postoperative central diabetes insipidus

Not Applicable
Recruiting
Conditions
Endocrine, nutritional and metabolic diseases
Registration Number
KCT0006488
Lead Sponsor
Seoul National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

? 19 years old or older and less than 80 years old
? Patients under follow-up at the Department of Endocrinology and Metabolism or Neurosurgery at Seoul National University Hospital who have had or are scheduled to undergo pituitary surgery
? Subjects who consent to donation of human material

Exclusion Criteria

? Renal-urinary structural disease
? Uncontrolled diabetes mellitus (HbA1C >8.5% within the last 3 months)
? Taking medications that affect the amount of urine (diuretics, SGLT-2 inhibitors, lithium, etc.)
? Patients with nephrogenic diabetes insipidus
? Patients with suspected primary polydipsia

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differentiation and predictive ability of copeptin concentration and change patterns measured before and after pituitary surgery for transient diabetes insipidus, permanent diabetes insipidus, and triphasic diabetes insipidus
Secondary Outcome Measures
NameTimeMethod
Predictive ability of copeptin concentration measured after pituitary surgery for diabetes insipidus ;The ability to differentiate between excessive fluid supply and diabetes insipidus of copeptin concentration in the occurrence of hypotonic polyuria after pituitary surgery;Differentiation between ACTH/steroid deficiency and diabetes insipidus in postoperative polyuria in copeptin concentration
© Copyright 2025. All Rights Reserved by MedPath